These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8105420)

  • 1. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies.
    Langlais PJ; Thal L; Hansen L; Galasko D; Alford M; Masliah E
    Neurology; 1993 Oct; 43(10):1927-34. PubMed ID: 8105420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study.
    Nazarali AJ; Reynolds GP
    Cell Mol Neurobiol; 1992 Dec; 12(6):581-7. PubMed ID: 1283363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choline acetytransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment.
    Mattila PM; Röyttä M; Lönnberg P; Marjamäki P; Helenius H; Rinne JO
    Acta Neuropathol; 2001 Aug; 102(2):160-6. PubMed ID: 11563631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease.
    Tiraboschi P; Hansen LA; Alford M; Merdes A; Masliah E; Thal LJ; Corey-Bloom J
    Arch Gen Psychiatry; 2002 Oct; 59(10):946-51. PubMed ID: 12365882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic dysfunction in diseases with Lewy bodies.
    Tiraboschi P; Hansen LA; Alford M; Sabbagh MN; Schoos B; Masliah E; Thal LJ; Corey-Bloom J
    Neurology; 2000 Jan; 54(2):407-11. PubMed ID: 10668703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity.
    Hansen L; Salmon D; Galasko D; Masliah E; Katzman R; DeTeresa R; Thal L; Pay MM; Hofstetter R; Klauber M
    Neurology; 1990 Jan; 40(1):1-8. PubMed ID: 2153271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology.
    Lippa CF; Smith TW; Perry E
    J Neural Transm (Vienna); 1999; 106(5-6):525-35. PubMed ID: 10443555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Lewy body variant of Alzheimer disease.
    Hansen LA
    J Neural Transm Suppl; 1997; 51():83-93. PubMed ID: 9470130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease.
    Dexter DT; Sian J; Rose S; Hindmarsh JG; Mann VM; Cooper JM; Wells FR; Daniel SE; Lees AJ; Schapira AH
    Ann Neurol; 1994 Jan; 35(1):38-44. PubMed ID: 8285590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes.
    Rossor MN; Svendsen C; Hunt SP; Mountjoy CQ; Roth M; Iversen LL
    Neurosci Lett; 1982 Feb; 28(2):217-22. PubMed ID: 7070710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neocortical lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease.
    Samuel W; Galasko D; Masliah E; Hansen LA
    J Neuropathol Exp Neurol; 1996 Jan; 55(1):44-52. PubMed ID: 8558171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease.
    Palmer AM; Wilcock GK; Esiri MM; Francis PT; Bowen DM
    Brain Res; 1987 Jan; 401(2):231-8. PubMed ID: 2434191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
    Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
    Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plaque-only Alzheimer disease is usually the lewy body variant, and vice versa.
    Hansen LA; Masliah E; Galasko D; Terry RD
    J Neuropathol Exp Neurol; 1993 Nov; 52(6):648-54. PubMed ID: 8229084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choline acetyltransferase immunohistochemistry in brains of Alzheimer's disease patients and controls.
    Nagai T; McGeer PL; Peng JH; McGeer EG; Dolman CE
    Neurosci Lett; 1983 Apr; 36(2):195-9. PubMed ID: 6866327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neocortical synapse density and Braak stage in the Lewy body variant of Alzheimer disease: a comparison with classic Alzheimer disease and normal aging.
    Brown DF; Risser RC; Bigio EH; Tripp P; Stiegler A; Welch E; Eagan KP; Hladik CL; White CL
    J Neuropathol Exp Neurol; 1998 Oct; 57(10):955-60. PubMed ID: 9786245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abeta1-42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD.
    Masliah E; Alford M; Adame A; Rockenstein E; Galasko D; Salmon D; Hansen LA; Thal LJ
    Neurology; 2003 Jul; 61(2):206-11. PubMed ID: 12874400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies.
    Dugger BN; Dickson DW
    Acta Neuropathol; 2010 Nov; 120(5):633-9. PubMed ID: 20721565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dementia with Lewy bodies versus pure Alzheimer disease: differences in cognition, neuropathology, cholinergic dysfunction, and synapse density.
    Samuel W; Alford M; Hofstetter CR; Hansen L
    J Neuropathol Exp Neurol; 1997 May; 56(5):499-508. PubMed ID: 9143263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anosmia is very common in the Lewy body variant of Alzheimer's disease.
    Olichney JM; Murphy C; Hofstetter CR; Foster K; Hansen LA; Thal LJ; Katzman R
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1342-7. PubMed ID: 16170073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.